Pro and pre B cells possess the long-term capacity to proliferate in vitro on stromal cells and interleukin 7 (IL-7) and can differentiate to surface immunoglobnlin (slg +) calls upon removal of IL-7 from the cultures. A key event in this differentiation is the extensive cell loss due to apoptosis. Because the proto-oncogene bcl-2 can promote cell survival, we established pre-B cell lines from E#-bcl-2 transgenic mice. These pre-B cells have the same properties as those derived from non-bcl-2 transgenic mice except that they do not die by apoptosis. This allowed us to study the fate of newly formed B cells in vitro for a longer period of time. Here we show that early during the differentiation of pre-B cells, upregulation of RAG-1 and RAG-2 expression go hand in hand with rearrangements of the Ig gene loci. Moreover, the newly formed sIg + B cells continue to express RAG-1 and RAG-2 and continue to rearrange L chain gene loci, even in the absence of proliferation, in an orderly fashion, so that gL + sIg + cells can become XL + sIg + or slg-cells, whereas M, + slg + cells can become sIg-, but not KL + sIg + ceils. Thus, deposition of a complete Ig molecule on the surface of a B cell does not automatically stop the Ig-rearrangement machinery.
T
he bcl-2 gene encodes a 26-kD c~ protein and a/3 form of 21 kD varying at the COOH-terminal end (1) . The bcl-2 protein is mainly expressed in B-and T-lymphocyte-lineage cells at defined stages of their differentiation (2) (3) (4) . It was originally identified as the locus translocated to the Ig H chain locus in the (t 14:18) (q32;q21) translocations found in most cases of human follicular lymphomas (5) (6) (7) (8) (9) . Translocations leave the coding regions intact but put the (onco)gene under the control of expression of the IgH locus, leading to constitutive high expression along the B-lineage pathway from early precursors to plasma cells. Although the exact functions of the bcl-2 gene are still unknown, it plays the role of rescuing cells from programmed cell death (apoptosis, characterized by chromatin condensation and by endonucleolytic cleavage of DNA into characteristic nucleosome ladders) (10, 11) , thereby prolonging the lifespan of the cell in which it is expressed. This has been shown for B-lineage, T-lineage, and other hematopoietic cells by transfection of the bd-2 gene (12, 13) and in bcl-2-transgenic (tg) 1 mice (14) (15) (16) (17) (18) (19) (20) . The bd-2 expression pattern in normal T-and B-lymphoid lineage cells suggests that it may play a role in changing the life span of antigen-selected lymphocytes to longevity (21, 22) . From all 1 Abbreviations used in this paper: HU, hydroxyurea; slg, surface Ig; tg, transgenic.
these studies it appeared reasonable to expect that constitutive bcl-2 expression in precursor (pre-) B cells of E#-bcl-2-tg-mice (16) (17) (18) would inhibit the apoptosis of B cells differentiating from long-term proliferating pre-B cells. This differentiation can be induced by removal of IL-7 from cultures of these pre-B cells which need stromal cells and IL-7 for continued proliferation (23) .
This paper compares the differentiation of normal pre-B with bcl-2 tg pre-B cells in vitro to surface Ig + (slg +) and sIg-B ceUs. The results show that proliferation on stromal cells and IL-7, and differentiation of bcl-2 tg pre-B cells upon removal of IL-7, is normal except that the differentiated B cells do not die by apoptosis. This allows an investigation of the state of the sIg + and sIg-cells, generated by productive and nonproductive, respectively, rearrangements of the H and L chain gene loci, their expression ofpre-B cell-specific and -related genes such as Vp~ and )~s (24) , and RAG-1 and RAG-2 (25, 26) , and their use of KL and XL chain gene loci during differentiation to sIg + B cells.
Materials and Methods
Animals and CelI Lines. E#-bcl-2 transgenic mice originally obtained from Drs. A. Harris and S. Cory, (Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia) and previously described (16) (17) (18) were bred in the breeding fadlities of the Basel Institute for Immunology. The presence of the bd-2 tg was ascertained by the presence of SV-40 DNA sequences flanking the bcl-2 tg (16) (17) (18) . The stromal cell line PA-6 was obtained from Dr.
H. A. Kodama (Ohu University, Japan). PA-6 cells and 3T3 fibroblasts transfected with the murine I1:7 cDNA were grown as described (23) .
Interleukins, Monoclonal Antibodies, Irarnunofluorescence, and Flow Cytometric Analysis. rib7, produced by the fibroblast cell line 3T3 transfected with the mouse I1:7 gene, was used at a concentration of 50-200 U/ml. The FITC-, PE-or biotin-conjugated mAb RAB-6B2 (anti-B220), R26-46 (M + X2 L chains), and 6C3 (anti-BP-1) were obtained from Pharmingen (San Diego, CA). The mAb $7 (anti-CD43), Ack4 (anti-c-kit), M41 (anti-/zH chain), 187.1 (anti-KL chain), and 4/1-101 (anti-M chain) were purified from culture supematant and conjugated as previously described (23) . Cell surface immunofluorescence and flow cytometric analyses were performed as described (27) . Cells expressing K or X L chains were sorted using the FACStar Plus | (Becton and Dickinson, Mountain View, CA).
Preparation of Pre.B Cell Lines.
Pre-B cell lines that possess the long-term capacity to proliferate on stromal cells in the presence of I1:7 were prepared from day 17-18 fetal liver and from 2-wk-old bone marrow cells as previously described (23, 27) . Throughout these experiments PA-6 cells were used as stromal cells. The influence of hydroxyurea on the proliferation and differentiation of our pre-B cells was studied using different concentrations. For proliferation, pre-B cell cultures were initiated at 5 x 104 cells/ml on PA-6 plus Ib7 in the presence of different concentrations of hydroxyurea. Cell growth was determined by [3H]thymidine uptake during the last 6 h of a 72-h culture period. For differentiation, pre-B cell cultures were initiated at 1-2 x 10 s cells/ml on PA-6 stromal cells without 1I:7 and in the presence of different concentrations of hydroxyurea. Differentiation was determined by measuring slg + cells after a 72-h culture period.
Northern Blot and Dot Blot Analysis. Total cellular KNA was extracted from cells with acid guanidinium-thiocyanate-phenolchloroform (28) . For Northern blot analysis 15 #g denatured total RNA per lane was fractionated on a 1.2% agarose-0.4 M formaldehyde gel and then blotted onto Gene Screen Plus | nylon membranes (Du Pont-Biotechnology Systems NEN, Boston, MA) by downward alkaline blotting. For dot blot analysis, 15 #g total RNA was denatured in 55% formamide, 7% formaldehyde, 50 mM NaH2PO4, pH 7.2, for 10 rain at 65~ serially diluted in steps of three in the same buffer, and applied to a Gene Screen Plus | nylon membrane with a Unifold | 96-well blotting apparatus (Schleicher & Schuell, Inc., Keene, NH) by gentle suction. The membrane was washed in 0.2 M NaH2PO4, pH 7.2, for 10 min, in H20 (tridist.) for 2 min and air-dried.
Filters were prehybridized in 7% SDS, 1 mM EDTA, 0.5 M NaHzPO4, pH 7.2, for 4 h at 65~ and hybridized in the same buffer overnight at 65~ with cloned fragments of CK, VpreB1, RAG-2, and/~-actin genes in M13mp18, labeled by second strand synthesis in a reaction primed by a 17-met sequencing primer (New England Biolabs, Beverly, MA) and c~-[3zP]dCTP. The probe for CM was a kind gift of Dr. Shunichi ~keda in our Institute and was labeled using a WQuick Prime | kit (Pharmacia, Uppsala, Sweden) according to the manufacturer's protocol.
Hybridized membranes were washed twice in 5% SDS, twice in 1% SDS, both in 40 mM NaH2PO4, pH 7.2, 1 mM EDTA at 65~ for 20 min each and were autoradiographed with a Kodak X-OMAT AR film (Eastman Kodak Co., Rochester, NY). Radioactivity on the blots was also visualized and quantified by means of a Phosphorlmager | with ImageQuant | software 3.0 (Molecular Dynamics, Inc., Sunnyvale, CA). Before rehybridization, blots were stripped of the hybridized radioactivity by washing the membranes four to five times in 0.01 x SSC, 0.01% SDS at 95~ for 2-3 min.
RNA Isolation, cDNA Synthesis, and PCR. BC1:2-5 cells were FACS | sorted after 5 d of differentiation and total RNA was isolated from 20,000 K +, 2~+, or K § -cells.
The cells were lysed in 100 #1 guanidinium-isothiocyanate solution (28), 10/~12 M Na-acetate, pH 4, and 100/~1 phenol/chloroform/isoamylalcoho125:24:1 (water saturated) were added, mixed (15 min, 4~
The upper phase was added to 120/~1 isopropanol and the RNA precipitated by centrifugation. The pellet was washed with 70% ethanol, air dried, and resuspended in 20/~1 water.
First strand synthesis was carried out using random hexamer primers (Boehringer-Mannhdrn, Mannheim, FRG) and Superscript Reverse Transcriptase (GIBCO BRL, Basel, Switzerland) in a total volume of 20/~1. 1/~1 of the cDNA preparation was subsequently used for PCR amplification. The primers for RAG-1 and KAG-2 were kindly provided by Dr. G.-K. Sim, Basel Institute for Immunology, and had the following sequences: RAG-1 5' CCAAGCTGCAGACA-TTCTAGCACTC; RAG-1 3' CAACATCTGCCTTCACGTCGA-TCC; RAG-2 5' CACATCCACAAGCAGGAAGTACAC; RAG-2 3' GGTTCAGC~ACATCTCCTACTAAG; The control primers for the housekeeping gene HPKT were kindly provided by Dr. M. V. Wiles, Basel Institute for Immunology. The sequences are published (29) .
All primers were designed to be intron-spanning to distinguish DNA contamination.
PCK reactions were performed on 1 #1 of the cDNA preparation (i.e., RNA from 1,000 cells) in a total volume of 20 #1 according to the enzyme manufacturer's conditions (Boehringer Mannheim). The temperature settings for the Perkin Elmer Cetus PCR Cycler (Norwalk, CT) were 94~ 20 s, 58~ 20 s, 72~ 40 s for 35 cycles.
Semiquantitative PCR Titration for K Rearrangements. BCL-2-5 cells on days 0, 1, 2, 3, and 4 of differentiation were counted by Trypan blue exclusion, lysed by boiling, and DNA prepared as described dsewhere (27) . DNA was diluted in threefold steps in 10 mM Tris-C1, pH 8.3, leading to DNA equivalents of 300, 100, 30, 10, and 3 cells, respectively, per 5 #1 of the dilution. The PCR reaction was performed according to the enzyme manufacturer's conditions (Boehringer Mannheim) in a final volume of 20 #1. The PCR primers (universal V~ and J~2 primers detecting V~-J~l and V,-J,2 rearrangements) and reaction conditions are described elsewhere (30) .
Half of the resulting PCR product was separated on a 1.5% agarose gel by electrophoresis. Bands of 536 (V~-JA) and 130 bp (V,-J~2) were visualized under UV light. All kl-2 tg pre-B-I cell lines, just as those from normal mice, expressed m R N A for the pre-B cell-specific genes Vr~eB, RAG-l, and RAG-2, but not KL and M. chain genes, as detected in Northern blot analyses (Fig. 1) . Fig. 2, bottom) . In contrast to normal pre-B-I cells, bcl-2 tg pre-B cells did not die by apoptosis (Fig. 2, top) . Cells remained viable during differentiation. However, the vast majority of the cells changed their phenotype. Within 3 d On the level of specific RNA expression, the surrogate L chain disappeared within 2-3 d, whereas expression of gL chain mENA became detectable after 2 d, and of XL chain mRNA after 3 d of differentiation (Fig. 1) . Surprisingly, the expression of RAG-1 and RAG-2 mRNA actually increased for the first 2 d of in vitro differentiation, before it began to decrease. This increase was seen in El~-bcl-2-tg as well as in normal cells. Using a limiting dilution PCR, IgL chain rearrangements were analyzed. About 1 in 300 cells at day 0 had a rearrangement, this was 1 in 100 at day 1, and more than 1 in 10 from day 2 of differentiation onwards.
l~sults

Establishment of Pre-B Cell Lines from bcl-2 tg Mic~
Differentiation to slg + B Cells Expressing Either K or XL
Chains. Within (Fig. 3) . Extensive apoptosis of the normal cells prevents an whether that would still allow differentiation to slg + B cells. Results in Fig. 4 show that HU at 10 -4 M or higher completely inhibits proliferation as measured by uptake of radioactive thymidine. On the other hand, the proportion of slg + B cells differentiating at these high concentrations of HU remained constant. The development of gL* slg + and XL + slg + B cells within 3 d in the presence 2 x 10-4 M HU yielded ratios of M. to KL chain-expressing slg + B cells indistinguishable from those obtained in the absence of HU (Fig. 3) . The results collectively suggest that differentiation to slg + B cells and maybe even the continued rearrangement of L chain gene loci can ocCUr in the absence of DNA synthesis and cell proliferation.
Discussion
Pre-B cells that possess the long-term capacity to proliferate on stromal cells and IL-7 can differentiate to sIg + B cells by removal of IL-7 from the culture system (23, 31, 32) . So far, extensive apoptosis (23) interfere with the normal pre-B cell differentiation pathway. The x/X ratio of Ig molecules in the serum as well as that of membrane-bound Ig on B lymphocytes in mice is >10. These high ratios of g to ~ can be explained by a regulatory model, in which rearrangements at the X loci are postulated to commence only after the g loci have been exhaustively and nonproductively rearranged. This model is supported by the fact that most of the K chain-expressing B cells have their X chain genes in germline configuration, whereas in X chainproducing B cells, the g chain genes are frequently rearranged. (33) (34) (35) (36) .
High g/h ratios can also be explained by stochastic models that postulate an intrinsic rearrangement activity which is higher for g than for X loci (36) (37) (38) (39) . The stochastic model has recently gained support from studies with mice in which the Ig X lOCUS was inactivated (40) (41) (42) . These studies demonstrate that rearrangements at the Ig X locus and the production of XL chain-expressing B cells can occur without rearrangements at the Ig g loCUs.
A third model argues that high K/X ratios in the periphery reflect antigen selection and stimulation and that newly generated B cells have x/X ratios near unity (42) . Our earlier published findings (31) as well as the data shown above have strongly argued against this model. We have shown that immature slg + B cells obtained from normal non-bcl-2 tg pre-B cells that differentiate in vitro in the absence of exogenous antigen have already g/X ratios of >10.
Our findings described here support the scenario in which K gene rearrangements are initially preferred over ~, genes. However, when the immature B cells can survive longer, the chances for X chain gene rearrangements increase and consequently the ratio of Jc over X light chain-expressing B cells decreases. These and other findings (35) (36) (37) (38) (39) (40) (41) ) reaffLml a stochastic model in which a higher intrinsic rearrangement activity of the g over the X gene loci appears to be responsible for the high K/X ratio found in normal mice.
Secondary rearrangements can in principle occur at several Ig loci. Thus far, two examples of V.-gene replacement in which an akeady rearranged V,D,J.-rearranged H chain loCUs could be altered with a second V, gene have been described (43, 44) . The ~cL chain locus has a series of V~c-and Jg-segments that allow subsequent rearrangements in an already rearranged locus by inversion or deletion of intervening sequences (45) (46) (47) (48) . In normal B cells, cirCUlar DNAs of rearranged VJs have been demonstrated of which a large part is in-frame and thus potentially functional (49) . Moreover in the/LH, xL chain-expressing NFS-5 tumor cells, XL chain rearrangement may occur and thus ~r chains can be exchanged by XL chains (50) . Hence, the rearrangement machinery of a B cell does not automatically stop after deposition of a complete Ig in the cell membrane.
Secondary rearrangements, also termed "receptor editing" (51, 52) could either silence unwanted specifidties and/or salvage B cells with new desirable specificities. Recent studies (51, 52) using mice expressing an autoantibody as a transgene have shown that immature B cells in the bone marrow of these mice can be rescued after encounter with their autoantigen by exchanging the transgenic L chain in the Ig molecule with an endogenously encoded L chain. This L chain replacement is possible because these immature B cells still express RAG-1 and RAG-2 (51). On the other hand, crosslinking of slg on immature B cell lines from N-rayc-tg mice which express slg as well as RAG-1 and RAG-2 simultaneously has been found to lead to a rapid and reversible downregulation of RAG-1 and RAG-2 expression (53). Therefore, occupancy of slg on (immature?) B cells can either downregulate (at least in N-myc-tg mice), or preserve (at least in autoantibody-tg mice) the expression of RAG-1 and RAG-2 and, consequently, the capacity to express another L chain. This indicates that the signals given to an immature B cell via slg, as in mature B cells, can result in different reactions of these cells. It remains to be seen how the mode of Igreceptor occupancy, additional cell contacts with the antigenpresenting environment, and secondary signals by cytokines influence these reactions.
Ongoing Ig gene rearrangements in slg + B cells are likely to generate B cells with more than one antibody specificity. In practice, this may be avoided by the rapid apoptosis of the immature B cells which leaves little time for secondary rearrangements, before the cells die, or before they are selected into the peripheral pool of mature B cells. This might also be the reason for the fact that the rescued peripheral B cell pool in mice with transgenic H and L chain genes encoding an autoantibody is relatively small (51) . These scenarios of early B cell development are reminiscent of similar stages of T cell development, where immature c~/~ TcR + thymocytes keep expressing RAG-1 and RAG-2 and continue to rearrange c~ chain gene loci until they are positively selected into the pool of MHC-restricted CD4 + or CD8 + T cells (54, 55) .
Immature lymphocytes from E#-bcl-2-tg mice of both T and B cell lineages appear suitable target cells to study the cellular and molecular requirements of positive selection into the peripheral, long-lived pools of cells.
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